澳大利亚足科医生在儿科的研究:一个图书识别分析
Helen A Banwell1, Peta Tehan2, Matthew Carroll3
1School of Allied Health and Human Performance, Adelaide University, Adelaide, South Australia, Australia.
Journal of foot and ankle research
|March 13, 2026
概括
澳大利亚儿科足部医学研究显示,参与度很高,但资金和证据水平较低. 需要进一步的研究,以提高儿童和青少年的护理质量.
科学领域:
- 图书统计学 图书统计学
- 儿科足部医学 儿科足部医学
- 脚和下肢研究研究 脚和下肢研究
背景情况:
- 澳大利亚儿科足部医学研究的文献分析.
- 专注于澳大利亚作者对足部和下肢的研究.
研究的目的:
- 为了对澳大利亚儿科足部医学研究进行文献分析.
- 识别出版物,引文和研究质量的趋势.
主要方法:
- 从1970年到2024年进行Scopus数据库搜索.
- 使用基于R的工具进行图书统计分析.
- 研究类型的分类,证据水平和资金.
主要成果:
- 发现了280篇文章,有8331个引用.
- Gait & Posture是最常见的期刊;悉尼大学是主要机构.
- 大多数研究集中在检测/诊断 (25%),I级证据低 (12%) 和资金 (25% 类别1,55% 没有资金).
结论:
- 儿科足部医学研究占澳大利亚足部/下肢研究的17%.
- 研究表明参与度很高,但资金不足,依赖3级证据.
- 需要更强大的方法来增强儿科患者的临床护理证据.
相关概念视频
Pedigree Analysis
90.4K
Overview
90.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion
349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacokinetics in Pediatric Patients: Drug Metabolism
309
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
309
Pharmacokinetics in Pediatric Patients: Drug Distribution
414
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
626
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
626
Analysis of Population Pharmacokinetic Data
893
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
893


